https://european-biotechnology.net/wp-content/uploads/2025/08/Lecanemab-e1756144217541.jpg394700Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-08-25 15:50:242025-08-25 15:50:24Alzheimer’s antibody Lecanemab launched in the EU
https://european-biotechnology.net/wp-content/uploads/2025/08/nathaliemoll-58-copy-e1755857744587.jpg153271Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-08-22 10:16:182025-08-22 10:16:18US and EU confirm tariff deal on pharmaceuticals, generics largely exempt
https://european-biotechnology.net/wp-content/uploads/2025/08/mode-of-action-details73-1030x722-1.png7221030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-08-21 08:15:042025-08-21 08:15:04Mallia Aesthetics is about to launch MAL-838
